RecruitingNot applicableNCT05615584

Spectrometry (MRM) Versus I 125 Radioimmunoassay (RIA) for Quantification of Orexin-A of Patients With Hypersomnolence

Studying Idiopathic hypersomnia

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University Hospital, Montpellier
Intervention
Quantitative mass spectrometry assay(diagnostic_test)
Enrollment
117 enrolled
Eligibility
8 years · All sexes
Timeline
2023 – 2025

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05615584 on ClinicalTrials.gov

Other trials for Idiopathic hypersomnia

Additional recruiting or active studies for the same condition.

See all trials for Idiopathic hypersomnia →

← Back to all trials